CCJ Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Cameco Corp (CCJ) is not a clear buy right now for a Beginner long-term investor with $50,000-$100,000 ready to deploy. The stock has strong long-term support from uranium demand and nuclear infrastructure themes, but the current technical setup is not ideal: momentum is weakening, the MACD is negative and expanding, and the price is sitting close to support rather than breaking out. Since the user is impatient and does not want to wait for a better entry, the best direct call is hold rather than chase it here.
CCJ closed at 99.97 after a strong 4.15% regular-session gain, which is positive short term. However, the MACD histogram is -1.265 and still deteriorating, showing bearish momentum underneath the recent bounce. RSI_6 at 35.206 is neutral-to-soft, not yet oversold enough to signal a strong reversal. Moving averages are converging, suggesting a decision point, but not a confirmed uptrend yet. Price is above S1 at 97.152 and below the pivot at 108.028, so the stock is trading in the lower part of its current range rather than in a confirmed breakout zone.
Long-cycle bullish theme remains intact for nuclear fuel and Western fuel-cycle infrastructure. Analysts continue to rate the stock positively, and recent commentary highlights improving fundamentals driven by decarbonization, energy independence, and power security. The company is also viewed as one of the higher-quality ways to express uranium and nuclear demand upside. Cameco’s ownership stake in Westinghouse adds additional long-term optionality tied to reactor demand and fuel services.
Analyst targets were mixed recently, including a lowered target from GLJ Research, which suggests a more cautious near-term setup even though the long-term view remains constructive. There is no strong insider, hedge fund, or congress buying signal to add confidence.
No usable latest-quarter financial snapshot was provided because the financial snapshot returned an error. As a result, there is no reliable quarter-by-quarter revenue or earnings growth data to assess here. Based on the available information, the investment case is being driven more by sector fundamentals and analyst conviction than by the latest reported quarterly financials.
Analyst sentiment remains positive overall, but the trend is mixed. Scotiabank raised its target to $175 and kept Outperform, citing improving fundamentals. William Blair initiated coverage at Outperform with a $165 fair value. GLJ Research lowered its target to C$152.60 from C$171.20 while keeping Buy, signaling a more cautious short-term tone. Net-net, Wall Street remains constructive on the long-term story, but near-term target changes show some hesitation rather than full-throttle bullishness.
